Keyphrases
Clinical Outcomes
100%
ARRIVE
100%
Paclitaxel-eluting Stent
100%
In-stent Restenosis
100%
Safety Outcomes
14%
Clinical Events
14%
Taxus
14%
Target Vessel
14%
High Risk
7%
Comorbidity
7%
Myocardial Infarction
7%
Revascularization
7%
Stent
7%
Patient Demographics
7%
2-year Outcome
7%
2-year Follow-up
7%
Complex Disease
7%
Exclusion Criteria
7%
Restenosis
7%
Event-free Survival
7%
Coronary Intervention
7%
Inclusion-exclusion
7%
Unselected Patients
7%
Stent Thrombosis
7%
Coronary Vessels
7%
Bare Metal Stent
7%
Real Patients
7%
Adverse Cardiac Events
7%
Target Lesion Revascularization
7%
Endovascular Brachytherapy
7%
Immunology and Microbiology
Revascularization
100%
Event Free Survival
100%
Target Lesion Revascularization
100%
Comorbidity
100%
Medicine and Dentistry
Paclitaxel
100%
In-Stent Restenosis
100%
Myocardial Infarction
7%
Revascularization
7%
Event Free Survival
7%
Patient Population
7%
Restenosis
7%
Brachytherapy
7%
Stent Thrombosis
7%
Coronary Vessel
7%
Target Lesion Revascularization
7%
Comorbidity
7%
Diseases
7%